MAIA

NYSEAMERICAN 已收盘

MAIA Biotechnology

1.11 USD
▼-0.03-2.63%
盘后 1.10 0.00%
2026-11-20
市值
$68.54M
市盈率
—
EPS
-0.49
股息率
—
52 周区间
0.87 – 3.19
成交量
508.77K
Beta
0.30
目标价
12.00
52W 低 0.8752W 高 3.19
价格走势

公司简介

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.